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Abstract
The present study aimed to identify biologically active secondary metabolites from 
the rare plant species, Pulsatilla patens subsp. patens and the cultivated P. vulgaris 
subsp. vulgaris. Chromatographic fractionation of the ethanolic extract of the roots 
of P. patens subsp. patens resulted in the isolation of two oleanane-type glycosides 
identified as hederagenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin 
3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (3.3 mg, patensin). HPLC 
analysis of the methanolic extract of the crude root of P. patens subsp. patens and P. 
vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin D (hederagenin 
3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside). 
Chromatographic analysis using GC-MS of the silylated methanolic extracts from 
the leaves and roots of these species identified the presence of carboxylic acids, 
such as benzoic, caffeic, malic, and succinic acids. The extracts from Pulsatilla spe-
cies were tested for their antifungal, antimicrobial, and antimalarial activities, and 
cytotoxicity to mammalian cell lines. Both P. patens subsp. patens and P. vulgaris 
subsp. vulgaris were active against the fungus Candida glabrata with the half-maximal 
inhibitory concentration (IC50) values of 9.37 µg/mL and 11 µg/mL, respectively. 
The IC50 values for cytotoxicity evaluation were in the range of 32–38 μg/mL for P. 
patens subsp. patens and 35–57 μg/mL for P. vulgaris subsp. vulgaris for each cell 
line, indicating general cytotoxic activity throughout the panel of evaluated cancer 
and noncancer cells.
Keywords
pasque flower subspecies; oleanane-type triterpenoid glycosides; carboxylic acids; 
antifungal and antimicrobial activities; cytotoxicity; medicinal applications
Introduction
Plants are known to produce different biologically active substances, including sec-
ondary metabolites. It had been reported that plants from the Pulsatilla genus contain 
ranunculin, anemonin, protoanemonin, triterpenes, and saponins (9%) of mainly the 
oleanane and lupane-type [1,2]. These metabolites were also subjected to analyses in order 
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[3,4]. The triterpene saponins were isolated from P. chinensis (Bunge) Regel [5], P. 
koreana Nakai [6], P. cernua (Thunb.) Bercht. et Opiz. [7], P. dahurica (Fisch. ex DC.) 
Spreng. [8], P. turczaninovii Kryl. et Serg. [9], P. nigricans Storck [10], P. pratensis (L.) 
Mill. [11], and P. patens subsp. multifida (G. A. Pritzel) Zämelis [12]. Polyphenolic 
compounds such as flavonoids and anthocyanidins are produced by P. montana subsp. 
balcana (Velen.) Zämelis & Paegle, P. halleri subsp. rhodopaea (Stoj. et Stef.) K. Krause, 
and P. slaviankae (Zimmer.) Jordanov & Kožuharov [13]. The saponins produced by 
Pulsatilla species show high biological activity across a wide range as an anticancer [14], 
neuroactive [15], neuroprotective [16], immunomodulating [17], cognitive function 
enhancing [18], antioxidant [19], antimicrobial [20], and cytotoxic agents [21].
Pulsatilla species are rarely of toxicological importance, as while they are moderately 
hazardous, they are mutagenic and contain cellular poison [22]. The active ingredient 
in fresh plant material, a terpenoid glucoside known as ranunculin, is broken down 
to protoanemonin [23]. Protoanemonin is a reactive compound with an exocyclic 
methylene group and is mutagenic, because it can bind to the SH-group of proteins and 
DNA. Protoanemonin is an irritant lactone 
that causes allergic dermatitis in human 
skin [24], and internally, paralysis of the 
central nervous system and gastrointestinal 
disturbance [25]. When the plant is dried, 
the protoanemonin dimerises to form the 
less toxic anemonin, if it has not already 
alkylated proteins [23].
Despite the potential toxicity of Pulsatilla 
species, their natural products have been 
used for centuries in traditional Chinese 
and Korean medicine for the treatment of 
many diseases and ailments. They are known 
as herbal drugs used for the homeopathic 
treatment of eye ailments, earache, stress, 
anxiety, tension, skin eruptions, rheuma-
tism, headaches, neuralgia, insomnia, hyper-
activity, bacterial skin infections, septicemia, 
bronchitis, coughs, and asthma [26].
The Pulsatilla genus is composed of 38 
species in the Northern Hemisphere [23]. 
The species of Pulsatilla patens subsp. patens 
and P. vulgaris subsp. vulgaris have not been 
extensively studied. The existing research 
focuses primarily on genetic characteristics 
of the species [27], ecology [28], and vari-
ous aspects of developmental biology [29]. 
Pulsatilla patens subsp. patens is a lowland 
species of Boreo-meridional-continental 
distribution [30] and is native to Europe, 
Russia, Mongolia, China, Canada, and the 
United States [31] (Fig. 1A).
Pulsatilla patens subsp. patens is an en-
dangered plant and is considered critically 
threatened in the Czech Republic [32], in-
cluded in the red data books of Germany 
as an endangered plant [33], vulnerable in 
Sweden [34], relatively restored in Lithuania, 
and in decreasing number in the St. Peters-
burg and Kaliningrad [35] regions of Russia, 
Latvia [36], and Slovakia [37]. In Finland 
and Estonia, the populations of P. patens 
subsp. patens are considered to be relics [38]. 
In Poland, P. patens subsp. patens has been 
strictly protected since 1958 and requires 
Fig. 1 Distribution of Pulsatilla patens subsp. patens (A) in Europe, Asia, and 
North America [31], and (B) in Poland [40].
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active protection [39]. On the territory of 
Poland, P. patens subsp. patens reaches the 
western border of its range and the number 
of its sites clearly decreases towards the west 
and south [40] (Fig. 1B).
Pulsatilla vulgaris subsp. vulgaris is a spe-
cies occurring across Central Europe, rang-
ing from France in the south to Sweden at 
its northern limit [31] (Fig. 2A) and is listed 
as “near threatened“ by the International 
Union for Conservation of Nature [41]. Cur-
rently, P. vulgaris subsp. vulgaris is listed 
as vulnerable (VU category) in Ukraine, 
Slovakia [42], Sweden [43], and the United 
Kingdom [44]. This species is also classified 
as endangered (EN category) in Germany 
[45] and Switzerland [46] and as critically 
endangered (CR category) in Austria [47]. 
In Poland, it is listed as an extinct (RE cat-
egory) species [48] and mainly cultivated. 
Pulsatilla vulgaris subsp. vulgaris is currently 
extinct in Poland on natural sites [49]. It was 
only reported at four sites before 1930 [40] 
(Fig. 2B) on the habitats of the pine forests 
of the All. Dicrano-Pinion.
The aim of this study was the identifica-
tion of biologically active secondary metabo-
lites from the rare plant species Pulsatilla 
patens subsp. patens and the cultivated P. 
vulgaris subsp. vulgaris. In the course of our 
study, we evaluated the extracts of leaves 
and roots of these plant species for their 
antifungal, antimicrobial, and antimalarial 




The leaves and roots of P. patens subsp. pat-
ens were collected in May 2013–2015 at the 
Knyszynska Forest near Bialystok City, NE 
Poland, while P. vulgaris subsp. vulgaris were obtained from cultivation at the Herbarium 
“The Herbal Corner” in May 2015, Podlaskie Province, NE Poland. Plant material was 
identified by Prof. Grażyna Łaska from the Bialystok University of Technology, Faculty 
of Civil and Environmental Engineering, Poland.
Extraction and chromatographical analysis
TLC/CC analysis. For thin layer chromatography (TLC) and column chromatography 
(CC), ethanolic extracts were prepared from roots of P. patens subsp. patens (K2). Dried 
roots of P. patens subsp. patens (10 g) were extracted with 1 L of 50% aqueous EtOH at 
room temperature for 12 h and then filtered. The extraction was repeated three times. 
The combined filtrates were concentrated in a vacuum evaporator to obtain a syrupy 
brown residue (0.95 g). Then 5 mg of ethanolic extract from roots of P. patens subsp. 
patens (K2) was transferred to normal and reverse phase (RP) TLC on silica gel with 
Fig. 2 Distribution of Pulsatilla vulgaris subsp. vulgaris (A) in Central Europe 
[31] and (B) in Poland [40].
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fluorescence (stationary phase). The following solvent system was used for normal 
phase TLC: hexanes–ethyl acetate (C6–H14–C4H8O2; 60:40), chloroform–methanol 
(CHCl3–MeOH; 90:10) (Fig. 3) and for reverse phase TLC: water–methanol (H2O–
MeOH; 30:70), water–methanol (H2O–MeOH; 70:30). The solvent system H2O–MeOH 
(30:70) was found to be best for RP-TLC. A solution of H2SO4–MeOH (5:95) and UV 
254 and 366 nm were used as a detecting reagent (Fig. 3). In the next step, an ethanolic 
extract of the roots of P. patens subsp. patens was fractionated by CC (0.9 g) using 
CHCl3–MeOH gradient (90:10). Compounds were eluted by reverse-phase C18 column 
using the H2O–MeOH (30:70) solvent system (Fig. 4). The structures of the isolated 
compounds were determined by 1H and 13C-NMR spectroscopy.
HPLC analysis. The fraction which exhibited the most potent activity was again 
chromatographed by high performance liquid chromatography (HPLC) using Agilent 
Technologies 1260 Infinity system. The HPLC profiles were determined at 35°C on a 
COSMOSIL Packed Column 5C-18-MS-II (4.6 μm × 250 mm) (Nacalai, USA) eluted 
with methanol (A) and water (B) as mobile phases in a linear gradient elution with the 
flow rate of 1 mL/min. The elution program was as follows: 0–8 min, 90% A to 77% 
Fig. 3 TLC image of the ethanolic extract of roots (K2) of Pulsatilla patens subsp. 
patens and identification of Compound 1 and 2.
Fig. 4 Column chromatography of the ethanolic extract of Pulsatilla patens 
subsp. patens roots and isolation of Compound 1 and 2.
5 of 17© The Author(s) 2019 Published by Polish Botanical Society Acta Soc Bot Pol 88(1):3613
Łaska et al. / Biologically active secondary metabolites from Pulsatilla species
A, 8–25 min, changed to 71% A, 25–40 min, to 60% A, 40–50 min, to 50% A, 50–75 
min, to 10% A, 75–80 min, to 0% A [50]. The volume of sample injected was 35 µL. 
Fluorescence was monitored by an Agilent 1260 Infinity Fluorescence Light Detector 
(Agilent Technologies, USA; 210 nm excitation and 460 nm emission wavelength). The 
analytical data were integrated using the Agilent OpenLAB software. The fraction was 
purified by HPLC to give Pulsatilla saponin D. The peak of Pulsatilla saponin D was 
identified based on retention time with respect to the reference standard (purchased 
from Toronto Research Chemicals) previously run in an analytical HPLC.
GC-MS analysis. The pressurized solvent extractions were performed using a Büchi 
E-916 Speed Extractor. The raw materials were extracted with methanol (leaves 32.3 g, 
and roots, 23.6 g of P. patens subsp. patens; leaves, 21.8 g and roots, 56.1 g of P. vulgaris 
subsp. vulgaris). The extraction time was 30 min, temperature 100°C and pressure 1.2 
× 107 Pa. Three extracts were prepared from each raw material. Extracts were filtered 
through paper filters. The methanol was dried using a rotor evaporator.
Each dry residue (10 mg) was redissolved with 1 mL of pyridine and 200 µL BSTFA 
[Ν,Ο-bis-(trimethylsilyl)-trifluoroacetamide] added. Next, the mixture was heated at 
60°C for 30 min. The solution was analyzed by gas chromatography / mass spectrometry 
(GC-MS) using an Agilent 7890A gas chromatograph equipped with an Agilent 5975C 
mass selective detector. The injection of a 1-µL sample was performed using an Agilent 
7693A autosampler. The separation was performed on an HP-5MS (30 m × 0.25 mm 
× 0.25 μm film thickness) fused silica column at a helium flow rate of 1 mL/min. The 
injector worked in split mode (1:5), and the injector temperature was 280°C. The initial 
column temperature was 50°C, rising to 310°C at 3°C/min and the final temperature was 
held for 10 min. The ion source and quadrupole temperatures were 230°C and 150°C, 
respectively. The ionization energy (EIMS) was 70 eV. The detection was performed in 
full scan mode from 41 to 600 amu.
After integration, the percentage of each component in the total ion current (TIC) 
was calculated. Mass spectral data and calculated retention indices were used to 
identify the compounds. The mass spectrometric identification was carried out with 
an automated system of GC-MS data processing supplied by the National Institute of 
Standards and Technology (NIST). Retention indices of the analytes were determined, 
taking into account C10–C40n-alkanes retention times and comparing them with the 
NIST database.
Antimicrobial assay
For the antimicrobial assay, we used the fungi Candida albicans ATCC 90028, C. 
glabrata ATCC 90030, C. krusei ATCC 6258, Cryptococcus neoformans ATCC 90113, 
and Aspergillus fumigatus ATCC 204305 and the bacteria Staphylococcus aureus ATCC 
29213, methicillin-resistant S. aureus ATCC 33591 (MRS), Escherichia coli ATCC 35218, 
Pseudomonas aeruginosa ATCC 27853, and Mycobacterium intracellulare ATCC 23068 
from the American Type Culture Collection (Manassas, VA). The testing was performed 
using a modified version of the CLSI method (formerly NCCLS) [51–54] except for M. 
intracellulare, where a modified method by Franzblau et al. [55] was used. All samples 
were diluted in 20% DMSO/saline and then transferred in duplicate to microplates. In 
order to obtain final target inocula, microbial inocula were prepared by correcting the 
optical density at 630 nm (OD630) of the microbe suspensions in the incubation broth. 
In each assay, drug controls were used, with ciprofloxacin (ICN Biomedicals, USA) for 
the bacteria and amphotericin B (ICN Biomedicals, Ohio) for the fungi. The readings 
were made for all organisms before and after incubation at either 530 nm using the 
Biotek Powerwave XS plate reader (Bio-Tek Instruments, USA) or 544 excitation / 590 
emission, (M. intracellulare, A. fumigatus) using the Polarstar Galaxy Plate Reader (BMG 
LabTechnologies, Germany). To determine the minimum fungicidal or bactericidal 
concentrations required, 5 µL was removed from each clear well, transferred to agar, 
and incubated. The MFC/MBC (the lowest test concentration that kills the organism) 
was also established.
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Antimalarial assay
In the antimalarial assay, the chloroquine sensitive (D6) strain of Plasmodium falciparum 
was used and plasmodial LDH activity was measured using the procedure devised by 
Makler and Hinrichs [56]. To the wells of a 96-well plate containing 10 µL of diluted 
sample, a suspension of red blood cells infected with P. falciparum of 200 µL was 
introduced, together with 2% parasitemia and 2% hematocrit in RPMI 1640 medium 
supplemented with 10% human serum and 60 µg/mL Amikacin. Then, the plate was 
incubated at 37°C for 72 h with 90% N2, 5% O2, and 5% CO2 using a modular incuba-
tion chamber. In order to determine the parasitic LDH activity, 20 µL of the incubation 
mixture was mixed with 100 µL of the Malstat reagent (Flow Inc., USA) and incubated 
at room temperature for 30 min. Then, 20 µL of a 1:1 mixture of NBT/PES (Sigma, 
USA) were added and the plate was incubated in the dark for 1 h. To stop the reaction, 
100 µL of a 5% acetic acid solution was added and the absorbance was read at 650 nm. 
The drug controls were artemisinin and chloroquine. The half-maximal inhibitory 
concentration (IC50) values were calculated on the basis of the dose response curves of 
growth inhibition using XLfit 4.2 (IDBS, USA).
Cytotoxicity assay
In the cytotoxicity assay, the root extract was tested against a panel of cancer and non-
cancer cell lines. In this assay, we used 96-well tissue culture-treated plates. The cells were 
seeded at a density of 25,000 cells/well and grown for 24 h. Next, samples of the extract 
at different concentrations were added and cells were incubated for 48 h. The neutral 
red method [57] was used to determine the cell viability. The IC50 values were obtained 
on the basis of dose response curves. Doxorubicin was used as the control drug.
Results
Chromatographic fractionation of the ethanolic extract (0.9 g) of the roots of P. patens 
subsp. patens resulted in the isolation of two oleanane-type glycosides identified as hed-
eragenin 3-O-β-d-glucopyranoside (2.7 mg) and hederagenin 3-O-β-d-galactopyranosyl-
(1→2)-β-d-glucopyranoside (3.3 mg, patensin) (Fig. 5).
30 




Fig. 5 Structures of two oleanane-type glycosides isolated from Pulsatilla patens subsp. patens.
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HPLC analysis of the silylated methanolic extract of the crude root of P. patens 
subsp. patens and P. vulgaris subsp. vulgaris revealed the presence of Pulsatilla saponin 
D – hederagenin 3-O-α-l-rhamnopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-
arabinopyranoside (Fig. 6). Analysis of the chromatographic spectra of the extracts 
from P. patens subsp. patens and P. vulgaris subsp. vulgaris showed similar spectra to the 
standard solution chromatogram of Pulsatilla saponin D. The other chromatographic 
peaks for the extracts of P. patens subsp. patens and P. vulgaris subsp. vulgaris also showed 
the presence of triterpenoid saponins, which will need to be investigated further. The 
Pulsatilla saponin D has not been isolated in Pulsatilla medicinal plants in Poland until 
now, with this type of study being conducted here for the first time. Pulsatilla saponin 
D, C47H76O17, has multiple demonstrated biological properties including antifungal, 
antimicrobial, and cytotoxic activities.
   A 
B               C 
D 
Pulsatilla saponin D. Synonyms: 3β-[(O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-α-L-
arabinopyranosyl)oxy]-23-hydroxyolean-12-en-28-oic acid; hederacolchiside A; hederagenin 3-O-[β-D-
glucopyranosyl(1→4)-[α-L-rhamnopyranosyl(1→2)]]-α-larabinopyranoside; hederagenin 3-O-α-L-rhamnopyranosyl-






Fig. 6 HPLC chromatogram of standards Pulsatilla saponin D – 1 (A); HPLC spectrum of the triterpenoid saponins 
(Pulsatilla saponin D – 1) in Pulsatilla patens subsp. patens (B); HPLC spectrum of the triterpenoid saponins (Pulsatilla 
saponin D – 1) in Pulsatilla vulgaris subsp. vulgaris (C) and the structure of Pulsatilla saponin D (1) isolated from Pulsatilla 
patens subsp. patens and Pulsatilla vulgaris subsp. vulgaris (D).
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Carbohydrates were the main components of the extracts from P. patens subsp. 
patens and P. vulgaris subsp. vulgaris. The content of carbohydrates in each extract 
from P. patens subsp. patens was over 60% while those from P. vulgaris subsp. vulgaris 
were over 90% carbohydrates. The analyzed extracts that were the most abundant were 
saccharose, glucopyranose and fructofuranose. The extracts from the leaves of these 
species revealed the presence of carboxylic acids, such as benzoic, caffeic, malic, and 
succinic acids. Furthermore, glyceric, quinic, and protocatechuic acids were identified 
in the leaf extracts of P. patens subsp. patens, while the roots extracts from P. vulgaris 
subsp. vulgaris contained the smallest amount of carboxylic acids (Tab. 1).
Microbiological assays of the root extracts showed activity against the fungal 
pathogen Candida glabrata, indicated by the IC50 value of 9.37 μg/mL for P. patens 
subsp. patens and 11 µg/mL for P. vulgaris subsp. vulgaris (Tab. 2, Tab. 3). This result is 
particularly important as with the increasing use of immunosuppressants, the number 
of cases of inflammation of mucous membranes and particular systems by C. glabrata 
have significantly increased, especially in people with human immunodeficiency virus. 
Candida glabrata has become the second most important agent responsible for surface 
(oral cavity, esophagus, vaginal, or urinary duct) or systemic inflammation. The main 
problem with the inflammation caused by C. glabrata is their innate resistance to azole 
antibiotics that are very effective against other Candida species. Treatment of C. glabrata-
caused inflammation often require the use of amphotericin B that is toxic for humans 
and can trigger undesired side effects [58]. It has been experimentally shown that the 
root extracts form Pulsatilla species can contribute to new, safer drugs in antifungal 
therapy against C. glabrata.
Tab. 1 Relative chemical composition (% of TIC) of Pulsatilla patens subsp. patens and P. vulgaris subsp. vulgaris extracts.











69.77 ±3.49 88.17 ±4.41 94.14 ±4.71 96.46 ±4.82
α-Fructofuranose 32,494 2.12 ±0.11 3.37 ±0.17 42,998 4.28 ±0.21 1.02 ±0.05
β-Fructofuranose 42,678 2.53 ±0.13 7.68 ±0.38 43,286 4.39 ±0.22 4.19 ±0.21
α-D-Glucopyranose 45,290 13.44 ±0.67 10.19 ±0.51 45,928 16.80 ±0.84 16.89 ±0.84
β-D-Glucopyranose 48,449 17.44 ±0.87 9.42 ±0.47 49,055 19.53 ±0.98 16.81 ±0.84
Saccharose 66,784 14.98 ±0.75 25.74 ±1.29 67,461 23.52 ±1.18 53.65 ±2.28
Carboxylic acids
such as:
21.83 ±1.09 3.33 ±0.17 1.13 ±0.06 0.07 ±0.01
Laevulic acid - - - 15,035 0.05 ±0.01 -
Benzoic acid 19,169 0.03 ±0.01 0.06 ±0.01 19,765 0.04 ±0.01 -
4-Hydroxyvaleric acid - - - 20,763 0.16 ±0.01 -
Succinic acid 22,526 0.34 ±0.02 0.17 ±0.01 23,108 0.07 ±0.01 -
Malic acid 30,260 1.04 ±0.05 1.62 ±0.08 30,861 0.73 ±0.04 0.07 ±0.01
2-Hydroxyglutaric acid - - - 32,448 0.04 ±0.01 -
(E)-Ferulic acid 50,432 0.01 ±0.01 0.02 ±0.01 - - -
(E)-Caffeic acid 51,967 1.49 ±0.08 - 52,588 0.06 ±0.01 -
Glyceric acid 23,728 8.46 ±0.42 0.05 ±0.01 - - -
3-Phenyllactic acid 33,465 - 0.28 ±0.01 - - -
Protocatechuic acid 41,965 2.12 ±0.11 - - - -
Shikimic acid 42,394 - 0.22 ±0.01 - - -
Quinic acid 44,256 7.58 ±0.38 0.58 ±0.03 - - -
Amino acids 2.24 ±0.11 0.58 ±0.03 - -
Other compounds 5.90 ±0.30 3.86 ±0.19 0.57 ±0.03 1.39 ±0.07
Unidentified compounds 0.17 ±0.01 4.06 ±0.20 4.16 ±0.21 2.08 ±0.10
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The extracts from the leaves and roots of this plant species showed lower ability to 
inhibit the growth of the four different fungi (Candida albicans, C. krusei, Aspergillus 
fumigatus, and Cryptococcus neoformans) and other bacteria (Staphylococcus aureus, 
MRSA, Escherichia coli, and Pseudomonas aeruginosa) pathogenic to humans (Tab. 2, 
Tab. 3). As far as C. albicans, A. fumigatus, E. coli, and P. aeruginosa are concerned, 
the leaf and root extracts have been found to show biological activity. Although their 
activity is rather low, the extracts are still highly valuable as C. albicans is a frequent 
fungus pathogen in humans. This species is responsible for the painful inflammation 
of mucous membranes, e.g., vagina inflammation in women or oral-pharyngeal thrush 
in AIDS patients. In certain groups of sensitive patients, this species is responsible for 
serious and life threatening bloodstream inflammation and subsequent inflammation 
of internal organs [59]. The extracts from Pulsatilla species are also attractive in fighting 
A. fumigatus, which is one of the most common saprophytic fungi in the air. With an 
increasing number of patients treated with immunosuppressants, the incidence of seri-
ous and usually lethal invasive aspergillosis has also considerably increased worldwide 
[60]. Extracts from Pulsatilla species are also promising agents for the treatment of E. 
coli caused inflammation. This bacteria strain is the dominant facultative anaerobic 
Tab. 2 The test results of the antimicrobial activity of leaf and root extracts of Pulsatilla patens subsp. patens and Pulsatilla vulgaris 
subsp. vulgaris (primary screen).
Tested strain
Extracts from 
leaves of P. p. 
(50 µg/mL)
Extracts from 
roots of P. p. 
(50 µg/mL)
Extracts from 
leaves of P. v. 
(50 µg/mL)
Extracts from 






C. albicans 2* 27 11 24 100 ND
C. glabrata 0 100 14 98 100 ND
C. krusei 0 17 15 16 100 ND
A. fumigatus 7 3 21 11 99 ND
C. neoformans 0 22 0 40 82 ND
S. aureus 0 8 7 16 ND 89
MRSA 0 10 9 9 ND 94
E. coli 5 11 20 24 ND 96
P. aeruginosa 4 4 7 11 ND 100
M. intracellulare 0 0 0 0 ND 72
* The results in %. ND – not determined; P. p. – Pulsatilla patens; P. v. – Pulsatilla vulgaris.




roots of P. patens
Extracts from 
roots of P. vulgaris Amphotericin B Ciprofloxacin
C. albicans NA NA 0.19 ND
C. glabrata 9.37* 11 0.37 ND
C. krusei NA NA 0.67 ND
A. fumigatus NA NA 1.17 ND
C. neoformans 42.27 NA 0.18 ND
S. aureus NA NA ND 0.09
MRS NA NA ND 0.08
E. coli NA NA ND 0.01
P. aeruginosa NA NA ND 0.07
M. intracellulare NA NA ND 0.37
* The results in IC50. ND – not determined; NA – not active at 200 µg/mL
10 of 17© The Author(s) 2019 Published by Polish Botanical Society Acta Soc Bot Pol 88(1):3613
Łaska et al. / Biologically active secondary metabolites from Pulsatilla species
component of the flora of the human large intestine. It 
can cause inflammation of the urinary tract, sepsis, men-
ingitis, intestinal diseases, and diarrhea, and is difficult 
to treat as it is resistant to antimicrobial agents [61]. The 
Pulsatilla extracts should also be considered in fighting 
P. aeruginosa, the opportunistic pathogen responsible for 
hospital infections in patients with immunodeficiency. 
This pathogen causes inflammation of the lungs related to 
the use of a respirator, inflammation of the urinary tract, 
wounds in patients with serious burns, as well as sepsis 
[62]. Unfortunately, the extracts considered are inactive 
against M. intracellulare.
In our antimalarial assays, the extracts from the leaves 
and roots showed low activity against the protozoan (27% of 
inhibition for P. patens subsp. patens and 1–8% for P. vulgaris 
subsp. vulgaris), while the antimalarial drug chloroquine 
(positive control) showed 94–98% inhibition (Tab. 4).
The root extracts showed cytotoxicity to all the cell lines included in the assay. As 
shown in Tab. 5, the IC50 for cytotoxicity of P. patens subsp. patens was in the range of 
32–38 μg/mL and for P. vulgaris subsp. vulgaris, 35–57 µg/mL for each cell line, indicat-
ing general cytotoxic activity throughout the panel of cancer and noncancer cells.
Discussion
The extract of the roots of P. patens subsp. patens revealed the presence of two oleanane-
type glycosides identified as hederagenin 3-O-β-d-glucopyranoside and hederagenin 
3-O-β-d-galactopyranosyl-(1→2)-β-d-glucopyranoside (patensin). Structures of both 
compounds were established via comparing 1H and 13C-NMR spectral data on compounds 
reported earlier by other authors [63,64]. Patensin, C42H68O14, a triterpenoid glycoside, 
was also isolated from the ethanolic extract of roots of P. patens subsp. multifida [63] 
and five oleanane-type glycosides and two triterpene saponins were also isolated from 
the roots of P. patens subsp. multifida [64]. Phytochemical studies of new secondary 
metabolites from P. patens subsp. multifida have revealed the presence of a hitherto 
unknown saponin [12]. This saponin isolated from the methanolic extract of this 
plant has been found to inhibit the growth of skin cancer. Roots from P. patens subsp. 
multifida have been used historically in traditional Chinese medicine [26] as the agent 
shows anticancer, antimalarial, and antibacterial properties. At present, it is used as a 
homeopathic drug for the treatment of the ear conditions, exanthema, rheumatism, 
bronchitis, coughing, asthma, as well as an agent for alleviating stress and anxiety.
The triterpene acid and triterpene glycosides (saponins Pulsatilla A and B) were 
isolated from the plant material of P. chinensis [65]. The triterpene acid shows high 
cytotoxic activity against the malignant cells of lung cancer. The triterpene saponins are 
used for the treatment of inflammatory conditions [66] and reveal high antiprotozoal 
Tab. 4 The test results of the antimalarial activity of leaf and 








Extracts from leaves of P. patens 0
Extracts from roots of P. patens 27
Extracts from leaves of P. vulgaris 8
Extracts from roots of P. vulgaris 1
Tab. 5 Cytotoxicity of Pulsatilla patens subsp. patens and P. vulgaris subsp. vulgaris roots extracts 
towards a panel of mammalian cell lines.
Sample name
IC50 µg/mL
SK-MEL KB BT-549 SK-OV-3 LLC-PK1 Vero
Root extract of 
P. patens
34.0 38.0 32.0 32.0 36.0 32.0
Root extract of 
P. vulgaris
44.0 42.0 57.0 35.0 42.0 39.0
Doxorubicin* 1.7 1.7 2.2 2.3 1.6 >5.0
Cell lines: SK-MEL – skin melanoma; KB – epidermal carcinoma; BT-549 – breast cancer; SK-OV-3 – 
ovarian cancer; LLC-PK1 – kidney epithelial; Vero – kidney fibroblast. * Positive control drug.
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[67], antibacterial [68], antiparasitic [69], antifungal [70], and molluscicidic [71] activi-
ties. These saponins have also been used for the treatment of indigestion, premenstrual 
tension syndrome, and psychosomatic disturbances [72].
Six new saponins, five lupanes, and one oleanane [hederagenin 3-O-β-d-
glucopyranosyl-(1→4)-β-d-glucopyranosyl-(1→3)-α-l-rhamnopyranosyl-(1→2)-α-l-
arabinopyranoside], along with 11 known saponins, were also isolated from the roots of 
P. koreana [2]. The extracts from P. koreana were also determined to contain ranunculin, 
anemonin, protoanemonins, triterpenes, and saponins (9%). As evidenced in studies on 
the pharmacological use of components isolated from the extract, its protoanemonins 
show antifungal properties and antibiotic activity. Moreover, the biologically active com-
pounds isolated from the root extract of P. koreana have been found to show anticancer 
[73], anti-inflammatory [74], antiparasitic [75], and antibacterial [76] activities.
HPLC analysis of the root extract of P. patens subsp. patens and P. vulgaris subsp. 
vulgaris revealed the presence of Pulsatilla saponin D – hederagenin 3-O-α-l-rham-
nopyranosyl(1→2)-[β-d-glucopyranosyl(1→4)]-α-l-arabinopyranoside. Results of 
numerous phytochemical studies have confirmed high content of triterpenoid saponins 
of lupane or oleanane-type in the extract of the root of P. koreana and P. chinensis [2,77] 
and their chromatographic spectra [50] are similar to those obtained for P. patens subsp. 
patens and P. vulgaris subsp. vulgaris (Fig. 7A). All structures of triterpenoid saponins 
(pulsatilloside, Pulsatilla saponin, anemoside, hederacolchiside, and cussosaponin) 
isolated from P. koreana roots were elucidated by comparative analysis of spectral 
data [78].
Analysis of HPLC fingerprints of different species of Pulsatilla (P. koreana, P. chinensis, 
P. ambigua, P. dahurica, P. turczaninovii) showed significant differences between their 
HPLC fingerprints, but with 10 common peaks (Fig. 7B). These common peaks not only 
can be used to classify and authenticate Pulsatilla species, but also provide important 
A 
B
Fig. 7 HPLC-ELSD chromatogram of mixed standards and 15 samples extract of Pulsatilla koreana 
Nakai with spectrum of the triterpenoid saponins (pulsatilloside E, Pulsatilla saponin H, anemoside 
B4, hederacolchiside E, and cussosaponin C-5) (A) [78], and 10 common peaks of different Pulsatilla 
species on HPLC fingerprint study (B) [50].
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references for HPLC fingerprints and quality control of Pulsatilla medicinal plants [50]. 
These studies confirmed chromatographic spectra can show differences depending 
on the Pulsatilla species. Significant differences between P. koreana and P. dahurica, 
and between P. turczaninovii and P. ambigua were observed. Slight differences in the 
chromatographic spectra were also found for P. patens subsp. patens and P. vulgaris 
subsp. vulgaris; however, the presence of the triterpenoid saponins and the biological 
activity of their plant extracts were demonstrated for the first time in this work. This 
is very important because the triterpenoid saponins, such as Pulsatilla saponin D 
(C47H76O17), have demonstrated multiple biological properties including antifungal, 
antimicrobial, and cytotoxic activities. These compounds are also produced from the 
root of several Pulsatilla species, including P. koreana [1], P. chinensis [79], and P. cernua 
[80]. In particular, Pulsatilla saponin D shows high cytotoxic activity against cancer 
cells. Pulsatilla saponin D isolated from the root of P. koreana showed potent inhibition 
rate of tumor growth (IR, 82%) at the dose of 6.4 mg/kg on BDF1 mice bearing Lewis 
lung carcinoma (LLC) cells [1]. This compound is also proving to be promising for the 
treatment of Alzheimer’s disease [15].
It has been reported that the extracts from other species containing triterpenoid 
saponins, with hederagenin being the active ingredient, showed marked inhibition 
of serotonin (5-HT), norepinephrine (NE), and dopamine (DA) transporters [81]. 
Monoamine transporter inhibition studies on pure isolated compounds have not been 
reported yet, hence the importance of performing CNS studies on isolated compounds 
from Pulsatilla species. In future, we will focus on pure isolated compounds from P. 
patens subsp. patens and P. vulgaris subsp. vulgaris and submit them to the Psychoactive 
Drug Screening Program (PDSP), Chapel Hill, NC for monoamine transporter inhibi-
tion studies for extracellular monoamines including serotonin (5-HT), norepinephrine 
(NE), and dopamine (DA) transporters. The two oleanane-type glycosides have been 
sent to the National Center for the Natural Product Research (NCNPR) at the University 
of Mississippi to evaluate their antimicrobial activity.
Currently, this preparation, which is called SB31, is undergoing phase II clinical 
studies in Korea. It was previously reported that SB31 exhibited cytotoxic activity 
against some human cancer cell lines and potent antitumor activity on a mouse tumor 
model. An active antitumor constituent from the roots of P. koreana was isolated and 
the main component was found to be deoxypodophyllotoxin (DPT), which exhibited 
antiangiogenic activity and good antitumor activity against mice bearing LLC cells. 
However, the DPT content of Pulsatillae Radix, which is an active constituent of SB31, 
is too low for discernible antitumor activity. This suggests that DPT is not the major 
constituent responsible for the antitumor activity of P. koreana roots.
The extracts from P. cernua have been found to contain anthocyanidins, as well as 
triterpene saponins and phytosterols [82]. The natural dyes isolated from P. cernua show 
antiallergic, antifungal, anticancer, and antiulcer activity. Moreover, they improve blood 
flow in coronary arteries and reduce blood pressure so are attractive substances for the 
treatment of atherosclerosis. The anthocyanidins isolated from the extracts have been 
used in medicine as perspiration-promoting agents in the treatment of colds and in 
the treatment of inflammation of the stomach and intestines.
The flavonoids and tannins isolated from the methanolic extract from P. nigricans 
show considerable antianxiety effect [83]. Pulsatilla nigricans is one of the species 
used in traditional medicine for the treatment of nervous exhaustion and anxiety. 
Therefore, their high activity permits their application for the treatment of depression. 
The confirmation of our results shows the extracts from P. nigricans can also be used 
as antifungal agents and to alleviate the weakness of an organism.
Phytochemical studies of the extracts from P. montana subsp. balcana, P. halleri 
subsp. rhodopaea, and P. slaviankae have shown polyphenolic compounds, flavonoids, 
and anthocyanidins [13]. The highest contents of these substances were established in 
the extracts from P. montana subsp. balcana and P. halleri subsp. rhodopaea. The anti-
oxidative properties of P. slaviankae were a consequence of the presence of astragalin, 
isoquercetin, quercetin, kaempferol, caffeic acid, and isorhamnetin in the aboveground 
shoots of this species [84]. The natural biologically active substances isolated from this 
species may play an important role in the protection of humans against breast cancer, 
colon cancer, prostate cancer, and leukemia. Phytochemical studies of plant material 
from the species P. montana subsp. balcana have also revealed the presence of caffeic 
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acid, chlorogenic acid, gallic acid, methylgallic acid, ferulic acid, and ellagic acid [85]. 
Our results also identified caffeic acid, and so are in some accordance with the observa-
tion of these previous studies. The therapeutic effects related to the presence of these 
polyphenolic compounds include diastole of blood vessels, and assistance in stabilizing 
the blood pressure of patients with heart disease and hypertension.
The chemical composition of extracts from the leaves and roots of P. patens subsp. 
patens and P. vulgaris subsp. vulgaris were significantly different. The leaf extracts, in 
contrast to the root extracts, contained up to 22% carboxylic acid for P. patens subsp. 
patens and 2% for those of P. vulgaris subsp. vulgaris, whereas the leaf extracts showed 
lower biological activity. Chemical composition of extracts from dry and raw materials 
from this species were slightly different (Łaska and Sienkiewicz, unpublished data), while 
the extracts from fresh material were the most rich with compounds. Upon drying, 
some compounds were lost through evaporation or destruction.
However, phytochemical analysis of P. patens subsp. patens and P. vulgaris subsp. 
vulgaris showed nearly similar results due to the presence of phytochemical constituents. 
A previous study on the chemotaxonomic characteristics of Pulsatilla species revealed 
that P. patens subsp. patens, P. vulgaris subsp. vulgaris, and P. grandis Wenderoth contain 
only delphinidin glycosides, whereas the remaining species [P. halleri subsp. rhodopaea 
(Stoj. & Stef.) K. Krause, P. montana subsp. balcana (Vel.) Zamels, P. pratensis (L.) 
Mill., P. rubra (Lamk.) Delarbre, and P. vulgaris subsp. vulgaris var. touranginiana E. G. 
Camus] contain pelargonidin and delphinidin glycosides [86]. Our studies revealed the 
presence of the triterpenoid saponins and the biological activity of the extracts from P. 
patens subsp. patens and P. vulgaris subsp. vulgaris. Therefore, isolated saponins have 
chemotaxonomic features that may be recognized as specific to Pulsatilla species.
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